Russell Investments Group Ltd. grew its position in Cutera, Inc. (NASDAQ:CUTR – Get Rating) by 847.8% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 50,963 shares of the medical device company’s stock after purchasing an additional 45,586 shares during the quarter. Russell Investments Group Ltd. owned about 0.26% of Cutera worth $2,254,000 as of its most recent SEC filing.
Other institutional investors and hedge funds also recently made changes to their positions in the company. Almanack Investment Partners LLC. acquired a new stake in Cutera during the third quarter worth approximately $25,000. Captrust Financial Advisors boosted its holdings in shares of Cutera by 592.2% in the 1st quarter. Captrust Financial Advisors now owns 533 shares of the medical device company’s stock valued at $37,000 after purchasing an additional 456 shares in the last quarter. Rockefeller Capital Management L.P. boosted its holdings in shares of Cutera by 2,861.8% in the 3rd quarter. Rockefeller Capital Management L.P. now owns 1,007 shares of the medical device company’s stock valued at $45,000 after purchasing an additional 973 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Cutera by 69.9% in the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,348 shares of the medical device company’s stock valued at $88,000 after purchasing an additional 966 shares in the last quarter. Finally, SG Americas Securities LLC acquired a new stake in shares of Cutera in the 4th quarter valued at $112,000.
Cutera Stock Down 5.2 %
Shares of NASDAQ:CUTR opened at $16.84 on Friday. The firm has a market cap of $333.94 million, a P/E ratio of -3.50 and a beta of 1.56. The company has a quick ratio of 3.19, a current ratio of 3.85 and a debt-to-equity ratio of 19.38. Cutera, Inc. has a 12-month low of $13.21 and a 12-month high of $54.91. The business has a fifty day simple moving average of $22.56 and a 200 day simple moving average of $33.30.
Wall Street Analysts Forecast Growth
A number of equities research analysts have weighed in on CUTR shares. Cantor Fitzgerald reduced their target price on Cutera from $33.00 to $21.00 in a report on Wednesday, May 10th. Stephens reiterated an “overweight” rating and issued a $46.00 price target on shares of Cutera in a research note on Friday, April 14th. Maxim Group cut Cutera from a “buy” rating to a “hold” rating in a research note on Thursday, March 30th. Piper Sandler initiated coverage on Cutera in a research note on Wednesday, May 10th. They issued an “underweight” rating and a $14.00 price target for the company. Finally, William Blair cut Cutera from an “outperform” rating to a “market perform” rating in a research note on Thursday, May 11th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and one has assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $32.75.
About Cutera
Cutera, Inc engages in the provision of laser and energy-based aesthetic systems for practitioners. It operates through the following segments: United States, Japan, Asia excluding Japan, Europe, and Rest of the World. Its products include enlighten, excel HR, excel V+, secret Pro, Juliet, secret RF, and xeo.
Featured Stories
- Get a free copy of the StockNews.com research report on Cutera (CUTR)
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Want to see what other hedge funds are holding CUTR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cutera, Inc. (NASDAQ:CUTR – Get Rating).
Receive News & Ratings for Cutera Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cutera and related companies with MarketBeat.com's FREE daily email newsletter.